Market research
QSI QuantumSi Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 158M
- P/E ratio
- Not available
- Analyst target
- 2.3
- Dividend yield
- Not available
- Beta
- 3.25
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US74765K1051
- Market cap
- 158M
- P/E ratio
- Not available
- Analyst target
- 2.3
- Dividend yield
- Not available
- Beta
- 3.25
About
About QuantumSi Inc
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.
Visit company websiteCommunity
Investor discussion
0 comments
Sign in to join the QSI discussion.
No comments yet
Start a focused discussion about QSI.